Anna Miller‐Larsson

1.3k total citations
49 papers, 1.0k citations indexed

About

Anna Miller‐Larsson is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Anna Miller‐Larsson has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Physiology, 24 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Anna Miller‐Larsson's work include Asthma and respiratory diseases (31 papers), Respiratory and Cough-Related Research (11 papers) and Inhalation and Respiratory Drug Delivery (8 papers). Anna Miller‐Larsson is often cited by papers focused on Asthma and respiratory diseases (31 papers), Respiratory and Cough-Related Research (11 papers) and Inhalation and Respiratory Drug Delivery (8 papers). Anna Miller‐Larsson collaborates with scholars based in Sweden, United States and United Kingdom. Anna Miller‐Larsson's co-authors include Ralph Brattsand, Lizbet Todorova, Gunilla Westergren‐Thorsson, Olof Selroos, H. Mattsson, Magnus Dahlbäck, Anders Tunek, Anna Runström, Christopher F. Rider and Paul Jansson and has published in prestigious journals such as Gastroenterology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Anna Miller‐Larsson

48 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Miller‐Larsson Sweden 19 580 575 168 129 76 49 1.0k
Heinz G. Hoymann Germany 14 294 0.5× 372 0.6× 97 0.6× 160 1.2× 39 0.5× 20 708
Maria Pieroni Italy 19 680 1.2× 736 1.3× 81 0.5× 99 0.8× 78 1.0× 41 1.1k
Soon Seog Kwon South Korea 23 487 0.8× 510 0.9× 232 1.4× 314 2.4× 113 1.5× 82 1.3k
Takashi Aikawa Japan 14 484 0.8× 443 0.8× 172 1.0× 120 0.9× 43 0.6× 41 884
Laurie C.K. Lau United Kingdom 10 919 1.6× 704 1.2× 143 0.9× 254 2.0× 44 0.6× 14 1.2k
Kittipong Maneechotesuwan Thailand 18 632 1.1× 473 0.8× 212 1.3× 318 2.5× 72 0.9× 44 1.2k
Alfons Torregó Spain 21 802 1.4× 853 1.5× 246 1.5× 300 2.3× 79 1.0× 49 1.7k
Tsutomu Tamada Japan 17 315 0.5× 404 0.7× 196 1.2× 93 0.7× 70 0.9× 86 854
Andrew J. Hirsh United States 15 200 0.3× 685 1.2× 377 2.2× 86 0.7× 96 1.3× 18 1.3k
Yasuo To Japan 18 566 1.0× 553 1.0× 199 1.2× 218 1.7× 116 1.5× 49 1.1k

Countries citing papers authored by Anna Miller‐Larsson

Since Specialization
Citations

This map shows the geographic impact of Anna Miller‐Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Miller‐Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Miller‐Larsson more than expected).

Fields of papers citing papers by Anna Miller‐Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Miller‐Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Miller‐Larsson. The network helps show where Anna Miller‐Larsson may publish in the future.

Co-authorship network of co-authors of Anna Miller‐Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Miller‐Larsson. A scholar is included among the top collaborators of Anna Miller‐Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Miller‐Larsson. Anna Miller‐Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaidi, Syed Saoud, et al.. (2019). Fetal Concentrations of Budesonide and Fluticasone Propionate: a Study in Mice. The AAPS Journal. 21(4). 53–53. 2 indexed citations
2.
Kobayashi, Yoshiki, Anna Miller‐Larsson, Kazuhiro Ito, et al.. (2014). Protein tyrosine phosphatase PTPRR regulates PP2A in mononuclear cells. European Respiratory Journal. 44(Suppl 58). P1467–P1467.
3.
Rider, Christopher F., Anna Miller‐Larsson, David Proud, Mark A. Giembycz, & Robert Newton. (2013). Modulation of transcriptional responses by poly(I:C) and human rhinovirus: Effect of long-acting β2-adrenoceptor agonists. European Journal of Pharmacology. 708(1-3). 60–67. 14 indexed citations
4.
Kobayashi, Yoshiki, Nicolas Mercado, Anna Miller‐Larsson, Peter J. Barnes, & Kazuhiro Ito. (2012). Increased corticosteroid sensitivity by a long acting β2 agonist formoterol via β2 adrenoceptor independent protein phosphatase 2A activation. Pulmonary Pharmacology & Therapeutics. 25(3). 201–207. 35 indexed citations
5.
Fang, Qiuhong, Nancy A. Schulte, Xingqi Wang, et al.. (2011). Effect of budesonide on fibroblast-mediated collagen gel contraction and degradation. European Respiratory Journal. 38(Suppl 55). p421–p421. 2 indexed citations
6.
Todorova, Lizbet, Leif Bjermer, Gunilla Westergren‐Thorsson, & Anna Miller‐Larsson. (2011). TGFβ-induced matrix production by bronchial fibroblasts in asthma: Budesonide and formoterol effects. Respiratory Medicine. 105(9). 1296–1307. 29 indexed citations
7.
Adner, Mikael, Bengt Larsson, Jesper Säfholm, Ian Naya, & Anna Miller‐Larsson. (2010). Budesonide Prevents Cytokine-Induced Decrease of the Relaxant Responses to Formoterol and Terbutaline, but Not to Salmeterol, in Mouse Trachea. Journal of Pharmacology and Experimental Therapeutics. 333(1). 273–280. 13 indexed citations
8.
Todorova, Lizbet, Leif Bjermer, Anna Miller‐Larsson, & Gunilla Westergren‐Thorsson. (2010). Relationship between matrix production by bronchial fibroblasts and lung function and AHR in asthma. Respiratory Medicine. 104(12). 1799–1808. 17 indexed citations
9.
Todorova, Lizbet, et al.. (2009). Budesonide/formoterol effects on metalloproteolytic balance in TGFβ-activated human lung fibroblasts. Respiratory Medicine. 103(11). 1755–1763. 21 indexed citations
10.
Johnson, Jill R., et al.. (2008). Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction. American Journal of Physiology-Lung Cellular and Molecular Physiology. 295(5). L780–L788. 18 indexed citations
11.
Lindahl, Maria, Monika Malm-Erjefält, Karin von Wachenfeldt, et al.. (2007). Cooperative Inhibitory Effects of Budesonide and Formoterol on Eosinophil Superoxide Production Stimulated by Bronchial Epithelial Cell Conditioned Medium. International Archives of Allergy and Immunology. 143(3). 201–210. 10 indexed citations
12.
Korn, Solange H., et al.. (2007). Differences in Endogenous Esterification and Retention in the Rat Trachea between Budesonide and Ciclesonide Active Metabolite. Drug Metabolism and Disposition. 35(10). 1788–1796. 6 indexed citations
13.
Miller‐Larsson, Anna & Olof Selroos. (2006). Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting β2-Agonists.. Current Pharmaceutical Design. 12(25). 3261–3279. 46 indexed citations
14.
Johansson, Ann‐Cathrine, et al.. (2006). Tissue Distribution of Ciclesonide and Budesonide in Mice. Journal of Allergy and Clinical Immunology. 117(2). S192–S192. 1 indexed citations
15.
Miller‐Larsson, Anna, B. Gustafsson, CG Persson, & Ralph Brattsand. (2001). Gut mucosal uptake and retention characteristics contribute to the high intestinal selectivity of budesonide compared with prednisolone in the rat. Alimentary Pharmacology & Therapeutics. 15(12). 2019–2025. 12 indexed citations
16.
Miller‐Larsson, Anna, Paul Jansson, Anna Runström, & Ralph Brattsand. (2000). Prolonged Airway Activity and Improved Selectivity of Budesonide Possibly Due to Esterification. American Journal of Respiratory and Critical Care Medicine. 162(4). 1455–1461. 69 indexed citations
17.
Miller‐Larsson, Anna, et al.. (1995). Mucosal uptake and retention of steroids in rat eleum. Possible explanation of topical efficacy in inflammatory bowel diseases (IBD). Gastroenterology. 108(4). A876–A876. 2 indexed citations
18.
Brattsand, Ralph, et al.. (1991). Attenuation of bradykinin-induced mucosal inflammation by topical budesonide in rat trachea. Inflammation Research. 34(1-2). 200–202. 4 indexed citations
19.
Miller‐Larsson, Anna & Ralph Brattsand. (1990). Topical anti-inflammatory activity of the glucocorticoid budesonide on airway mucosa. Evidence for a “hit and run” type of activity. Inflammation Research. 29(1-2). 127–129. 38 indexed citations
20.
Miller‐Larsson, Anna. (1980). A model of spatial distribution of muscle fibres of a motor unit in normal human limb muscles.. PubMed. 20(4-5). 281–98. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026